Telehealth Tool Shows 50% Reduction in Cardiovascular Hospital Readmissions
February 13th 2024Cardiac Solutions, a physician-owned practice specializing in personalized treatment plans, used RevUp Remote Patient Monitoring and Chronic Care Management to achieve these cardiovascular readmission rates.
Read More
Expert Discusses Quality Standards' Role in the Evolution of Biosimilars and Biologics Landscape
February 13th 2024Fouad Atouf, senior vice president of global biologics at US Pharmacopeia, discusses how established quality standards, drawing from the realm of small molecule drugs and evolving to meet the complexities of biologics, play a pivotal role in fostering trust.
Watch
AI Algorithm Demonstrates Ability to Predict the Efficacy of Sertraline in Patients With Depression
February 12th 2024Despite the tool’s ability to predict efficacy of sertraline in patients with major depressive disorder, the investigators note that future research will seek to improve the algorithm.
Read More
USP Expert Discusses Concerns on Biosimilar Safety and Efficacy Through Quality Standards
February 12th 2024Fouad Atouf, senior vice president of global biologics at US Pharmacopeia, discusses the importance of robust quality standards in addressing concerns regarding biosimilar safety and efficacy.
Watch
Let’s Not Forget the Silent Killer: Hypertension
February 9th 2024The prevalence of hypertension continues to increase amongst adults in the United States, leading to other cardiovascular conditions. Lifestyle changes and medication adherence are essential for appropriate hypertension management.
Read More
Biosimilar Adalimumab, Etanercept Have Equivalent Effectiveness to Reference Drugs Over 48 Months
February 9th 2024The levels of disease activity after 6 months of tumor necrosis factor-α inhibitors could help predict the response to therapy at 4 years for those who have long-standing rheumatoid arthritis.
Read More